Theoretical characterization of substrate access/exit channels in the human cytochrome P450 3A4 enzyme: involvement of phenylalanine residues in the gating mechanism.
The human cytochrome P450 3A4 mono-oxygenates approximately 50% of all drugs. Its substrates/products enter/leave the active site by access/exit channels. Here, we perform steered molecular dynamics simulations, pulling the products temazepam and testosterone-6betaOH out of the P450 3A4 enzyme in order to identify the preferred substrate/product pathways and their gating mechanism. We locate six different egress pathways of products from the active site with different exit preferences for the two products and find that there is more than just one access/exit channel in CYP3A4. The so-called solvent channel manifests the largest opening for both tested products, thereby identifying this channel as a putative substrate channel. Most channels consist of one or two pi-stacked phenylalanine residues that serve as gate keepers. The oxidized drug breaks the hydrophobic interactions of the gating residues and forms mainly hydrophobic contacts with the gate. We argue that product exit preferences in P450s are regulated by protein-substrate specificity.
Fishelovitch
Dan
D
Department of Human Molecular Genetics and Biochemistry, Sackler Institute of Molecular Medicine, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel.
Shaik
Sason
S
Wolfson
Haim J
HJ
Nussinov
Ruth
R
D001665:Binding Sites; D020134:Catalytic Domain; D003198:Computer Simulation; D051544:Cytochrome P-450 CYP3A / Q000737:chemistry* / Q000378:metabolism; D006801:Humans; D010649:Phenylalanine / Q000737:chemistry* / Q000378:metabolism; D011485:Protein Binding; D013379:Substrate Specificity; D013693:Temazepam / Q000737:chemistry; D013739:Testosterone / Q000737:chemistry
D013739:Testosterone; D010649:Phenylalanine; D013693:Temazepam; D051544:Cytochrome P-450 CYP3A; C510163:CYP3A4 protein, human